Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?

Clin Cancer Res. 1999 Sep;5(9):2286-8.

Authors

G B Mills, R Schmandt, D Gershenson, R C Bast

PMID: 10499594

No abstract available

Publication types

Comment
Editorial

MeSH terms

Female
Humans
Individuality
Nucleic Acid Hybridization
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / genetics*
Predictive Value of Tests